newsfilter
← Latest News
GlobeNewswire·

MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024

ROCKVILLE, MD, Sept. 08, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based